Francisco Gea

1.0k total citations
25 papers, 363 citations indexed

About

Francisco Gea is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Francisco Gea has authored 25 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Francisco Gea's work include Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (7 papers). Francisco Gea is often cited by papers focused on Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (7 papers). Francisco Gea collaborates with scholars based in Spain, Australia and United States. Francisco Gea's co-authors include Luís Rábago, E Quintanilla, Iván Guerra, María Delgado, José Luis Castro, Ricardo Llorente, María Jesús García García, J. Enrique Domínguez‐Muñoz, Fernando Carballo and Blas Gil Extremera and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Francisco Gea

23 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francisco Gea Spain	9	213	172	133	109	92	25	363
Francesco Crafa Italy	11	286 1.3×	179 1.0×	50 0.4×	76 0.7×	77 0.8×	44	388
Şehmus Ölmez Türkiye	10	144 0.7×	72 0.4×	120 0.9×	97 0.9×	60 0.7×	39	298
Chiara Giordanino Italy	12	147 0.7×	100 0.6×	221 1.7×	250 2.3×	52 0.6×	21	401
Long-Bin Jeng Taiwan	13	218 1.0×	100 0.6×	65 0.5×	107 1.0×	70 0.8×	28	385
Paolo Cecinato Italy	11	192 0.9×	147 0.9×	173 1.3×	179 1.6×	92 1.0×	45	417
Gun Hyung Na South Korea	12	236 1.1×	100 0.6×	97 0.7×	197 1.8×	87 0.9×	28	369
Chih-Yung Yu Taiwan	11	191 0.9×	99 0.6×	77 0.6×	143 1.3×	51 0.6×	36	389
Hirotaka Tokai Japan	11	155 0.7×	66 0.4×	54 0.4×	80 0.7×	83 0.9×	30	279
Rui Gaspar Portugal	11	149 0.7×	79 0.5×	176 1.3×	125 1.1×	61 0.7×	41	371
Fatih Tekın Türkiye	11	161 0.8×	79 0.5×	127 1.0×	117 1.1×	26 0.3×	45	304

Countries citing papers authored by Francisco Gea

Since Specialization

Citations

This map shows the geographic impact of Francisco Gea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Gea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Gea more than expected).

Fields of papers citing papers by Francisco Gea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Gea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Gea. The network helps show where Francisco Gea may publish in the future.

Co-authorship network of co-authors of Francisco Gea

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Gea. A scholar is included among the top collaborators of Francisco Gea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Gea. Francisco Gea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lazarus, Jeffrey V., Marcela Villota‐Rivas, Inmaculada Fernández, et al.. (2022). A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid. SHILAP Revista de lepidopterología. 2(1). 20–20. 5 indexed citations

García, Laura Martínez, Mario Rodríguez-Domínguez, Javier Martínez‐Sanz, et al.. (2022). The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves. Frontiers in Public Health. 10. 880435–880435. 7 indexed citations

López, Sonia Alonso, María Luisa Manzano, Francisco Gea, et al.. (2020). A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis. Hepatology. 72(6). 1924–1934. 56 indexed citations

Fernández, Inmaculada, María Luisa Gutiérrez García, Lourdes Domínguez, et al.. (2019). SAT-229-Risk of hepatocellular carcinoma in patients with chronic hepatitis C and stage-3 liver fibrosis after sustained virological response with direct acting antivirals. Journal of Hepatology. 70(1). e731–e731. 3 indexed citations

Perelló, Christie, Elba Llop, Inmaculada Fernández, et al.. (2019). FRI-496-Recurrence of hepatocellular carcinoma in patients with complete response treated with direct acting antivirals in clinical practice. Journal of Hepatology. 70(1). e617–e617.

Cabezas, Joaquín, Inmaculada Fernández, Susana Llerena, et al.. (2019). FRI-225-Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection. Journal of Hepatology. 70(1). e493–e494. 2 indexed citations

Aguilera, Lara, Ana García García de Paredes, Enrique Rodríguez de Santiago, et al.. (2018). Current allocation policy is favorable for patients with hepatocellular carcinoma waiting for liver transplantation. Digestive and Liver Disease. 50(12). 1345–1350. 3 indexed citations

Paredes, Ana García García de, Luís Téllez, Miguel Ángel Rodríguez-Gandía, et al.. (2017). Incidence, predictive factors and impacts of acute kidney injury in cirrhotic patients hospitalized for cellulitis. Liver International. 38(2). 285–294. 7 indexed citations

Londoño, María‐Carlota, J.M. Pascasio, Carme Baliellas, et al.. (2016). Efficacy and Tolerability of Interferon-Free Antiviral Therapy in Kidney Transplant (KT) Recipients with Chronic Hepatitis C: Real-Life Data from the Spanish National Registry (HEPA-C). Journal of Hepatology. 64(2). S793–S794. 3 indexed citations

10.

Calleja, José Luís, J.M. Pascasio, Belén Ruíz‐Antorán, et al.. (2014). Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis. Liver International. 35(1). 90–100. 15 indexed citations

11.

Calleja, José Luís, J.M. Pascasio, Belén Ruíz‐Antorán, et al.. (2013). 799 EFFICACY AND SAFETY OF TRIPLE-THERAPY WITH PEGINTERFERON-RIBAVIRIN, AND BOCEPREVIR AS COMPASSIONATE-USE IN SPANISH PATIENTS WITH HEPATITIS C GENOTYPE 1 WITH SEVERE FIBROSIS: INTERIM-ANALYSIS AT 12 WEEKS. Journal of Hepatology. 58. S326–S327. 1 indexed citations

12.

Quintanilla, E, José Luis Castro, Luís Rábago, et al.. (2012). Is the use of prophylactic hemoclips in the endoscopic resection of large pedunculated polyps useful? A prospective and randomized study. PubMed. 2(4). 183–188. 34 indexed citations

13.

García–Bengoechea, Manuel, et al.. (2012). Prácticas de cribado del virus de la hepatitis B previo a las terapias de riesgo de reactivación vírica en diferentes especialidades médicas. Proyecto HEBRA. Medicina Clínica. 139(11). 498–501. 2 indexed citations

14.

Rábago, Luís, et al.. (2009). Is outpatient ERCP suitable, feasible, and safe? The experience of a Spanish community hospital. Surgical Endoscopy. 24(7). 1701–1706. 16 indexed citations

15.

Rábago, Luís, María Delgado, Iván Guerra, et al.. (2006). Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis. Endoscopy. 38(8). 779–786. 93 indexed citations

16.

Rábago, Luís, María Delgado, Iván Guerra, et al.. (2006). Tratamiento endoscópico de fístulas gastrointestinales con un pegamento biológico tisular. Gastroenterología y Hepatología. 29(7). 390–396. 15 indexed citations

17.

Rábago, Luís, et al.. (2004). Intraoperative ERCP for the Management of Choledocholithiasis: A Comparative Study. Gastrointestinal Endoscopy. 59(5). P199–P199. 2 indexed citations

18.

Domínguez‐Muñoz, J. Enrique, et al.. (1993). Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis. Digestive Diseases and Sciences. 38(3). 507–513. 42 indexed citations

19.

Rábago, Luís, et al.. (1992). Sonographic features of arterioportal fistula. Journal of Clinical Ultrasound. 20(4). 291–293. 2 indexed citations

20.

Extremera, Blas Gil, et al.. (1991). Low serum levels of ?-interferon, ?-interferon, and interleukin-2 in alcoholic cirrhosis. Digestive Diseases and Sciences. 36(9). 1209–1212. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact